SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-057049
Filing Date
2020-05-06
Accepted
2020-05-05 19:50:23
Documents
2
Period of Report
2020-05-05
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2018754d1_8k.htm 8-K 29320
2 EXHIBIT 99.1 tm2018754d1_ex99-1.htm EX-99.1 9682
  Complete submission text file 0001104659-20-057049.txt   40386
Mailing Address 5 KIRYAT HAMADA ST PO BOX 45032 JERUSALEM L3 9777401
Business Address 5 KIRYAT HAMADA ST PO BOX 45032 JERUSALEM L3 9777401 972-2-5486555
Anchiano Therapeutics Ltd. (Filer) CIK: 0001534248 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38807 | Film No.: 20850717
SIC: 2834 Pharmaceutical Preparations